SCHEMBL4005746

SCHEMBL4005746

O=C(O)N1CCN(S(=O)(=O)c2cccc(Br)c2)CC1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 1/20 0.60
▸ KMT2A Q03164 2/20 0.59
▸ MEN1 O00255 1/20 0.59
▸ MBTD1 Q05BQ5 1/20 0.56
▸ L3MBTL3 Q96JM7 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.51
▸ MAPT P10636 1/20 0.51
▸ IL1RN P18510 1/20 0.51
▸ SIRT2 Q8IXJ6 1/20 0.51
▸ USP2 O75604 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ CNR1 P21554 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ LMNA P02545 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30754633 0.85 GPR183 (0.57) GPR183KMT2AMEN1MBTD1L3MBTL3
SCHEMBL24762607 0.83 GPR183 (0.58) GPR183KMT2AMEN1MBTD1L3MBTL3
SCHEMBL6744239 0.82 ALDH1A1 (0.71) KMT2AALDH1A1USP2PKMNPC1
SCHEMBL2933909 0.82 KMT2A (0.68) GPR183KMT2AMEN1ALDH1A1MAPT
SCHEMBL5443874 0.81 GPR183 (0.63) GPR183KMT2AALDH1A1MAPTPKM
SCHEMBL3384758 0.81 MBTD1 (0.68) GPR183KMT2AMEN1MBTD1L3MBTL3
SCHEMBL263317 0.81 MBTD1 (0.73) KMT2AMEN1MBTD1L3MBTL3ALDH1A1
SCHEMBL2378015 0.80 TGM2 (0.54) GPR183KMT2AMEN1MBTD1L3MBTL3
SCHEMBL2379666 0.80 POLB (0.65) KMT2AMEN1MBTD1L3MBTL3PKM
SCHEMBL265068 0.80 MBTD1 (0.71) KMT2AMEN1MBTD1L3MBTL3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116606292-A Pyrido [1,2-a ] pyrimidinone derivatives containing sulfonamide unit, preparation method and application thereof 贵州大学 2023-08-18 — — CN disclosed
EP-3233835-A1 BENZAZEPINE SULFONAMIDE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2017-10-25 — — EP disclosed
WO-2016096778-A1 BENZAZEPINE SULFONAMIDE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2016-06-23 — — WO disclosed
US-7494994-B2 Phenylpyridylpiperazine compounds LES LABORATOIRES SERVIER (FR) 2009-02-24 — — US disclosed
US-20060258670-A1 New phenylpyridylpiperazine compounds LES LABORATOIRES SERVIER (FR) 2006-11-16 — — US disclosed
WO-2006120349-A1 NOVEL PHENYL-PYRIDINYL-PIPERAZINE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES LES LABORATOIRES SERVIER (FR) 2006-11-16 — — WO disclosed
EP-1721897-A1 Phenylpyridinylpiperazin derivatives, the process to make them and the pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2006-11-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060258670-A1 New phenylpyridylpiperazine compounds HRH4, HRH3, HRH2 GPR183 320/4885KMT2A 1578/4885MEN1 4003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback